Asenapine maleate

This classification denotes an antipsychotic agent with the molecular formula C17H16ClNO.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CU9463U2E2, chemically known as 1h-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-,(3ar,12br)-rel-, (2z)-2-butenedioate (1:1) but more generally known as asenapine maleate, which bears US NIH Compound Identifier 6440510. The base compound, Asenapine, most often comes in base and maleate forms. European Medicines Agency schedules Asenapine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30493. Most nations, for tariff and trade purposes, schedule asenapine maleate under HS 29349990 and SITC 51579. As of Q4 2014, ASENAPINE MALEATE remains US FDA's Preferred Term for this commodity. Asenapine maleate bears US NLM identifiers UMLS ID C2719618 and NCI Concept Code C79727. SMILES: CN1C[C@H]2C3CCCCC3OC4CCC(CC4[C@@H]2C1)CL.C(=C\C(=O)O)\C(=O)O.